Alterations in the TOP2A and HER2 genes: association with adjuvant anthracycline sensitivity in human breast cancers

J Natl Cancer Inst. 2009 May 6;101(9):615-8. doi: 10.1093/jnci/djp092. Epub 2009 Apr 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anthracyclines / administration & dosage
  • Antigens, Neoplasm / genetics*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics*
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • DNA Topoisomerases, Type II / genetics*
  • DNA-Binding Proteins / genetics*
  • Female
  • Gene Amplification*
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB-2*
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • Poly-ADP-Ribose Binding Proteins
  • Predictive Value of Tests

Substances

  • Anthracyclines
  • Antigens, Neoplasm
  • DNA-Binding Proteins
  • Poly-ADP-Ribose Binding Proteins
  • DNA Topoisomerases, Type II
  • TOP2A protein, human